Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.

Perella D, Fiks AG, Jumaan A, Robinson D, Gargiullo P, Pletcher J, Forke CM, Schmid DS, Renwick M, Mankodi F, Watson B, Spain CV.

Pediatrics. 2009 May;123(5):e820-8. doi: 10.1542/peds.2008-3310. Erratum in: Pediatrics. 2009 Aug;124(2):846.

PMID:
19403475
2.
3.

Varicella prevention in the United States: a review of successes and challenges.

Marin M, Meissner HC, Seward JF.

Pediatrics. 2008 Sep;122(3):e744-51. doi: 10.1542/peds.2008-0567. Review.

PMID:
18762511
4.

Effectiveness of live varicella vaccine.

Takahashi M.

Expert Opin Biol Ther. 2004 Feb;4(2):199-216. Review.

PMID:
14998778
5.

Varicella zoster vaccines.

Creed R, Satyaprakash A, Ravanfar P.

Dermatol Ther. 2009 Mar-Apr;22(2):143-9. doi: 10.1111/j.1529-8019.2009.01226.x. Review.

PMID:
19335725
6.

Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.

Watson B.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S143-6. doi: 10.1086/522130. Review.

PMID:
18419388
7.

Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.

Breuer J, Schmid DS, Gershon AA.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S147-51. doi: 10.1086/529448. Review.

PMID:
18419389
8.

Modified chickenpox in children immunized with the Oka/Merck varicella vaccine.

Watson BM, Piercy SA, Plotkin SA, Starr SE.

Pediatrics. 1993 Jan;91(1):17-22. Review.

PMID:
8416499
9.

[Primary varicella-zoster virus infection--current knowledge, diagnostic and therapeutic approaches].

Cvjetković D, Jovanović J, Hrnjaković-Cvjetković I.

Med Pregl. 2000 May-Jun;53(5-6):272-6. Review. Croatian.

PMID:
11089369
10.

[Varicella zoster virus vaccine--a review].

Petersen CS, Buhl MR, Heilmann CJ.

Ugeskr Laeger. 1997 Feb 17;159(8):1081-5. Review. Danish.

PMID:
9072851
11.

The safety profile of varicella vaccine: a 10-year review.

Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S165-9. doi: 10.1086/522125. Review.

PMID:
18419392
12.

Varicella vaccine.

Chartrand SA.

Pediatr Clin North Am. 2000 Apr;47(2):373-94. Review.

PMID:
10761509
13.

The impact of varicella vaccination in the United States.

Hambleton S, Gershon AA.

Semin Pediatr Infect Dis. 2005 Jan;16(1):38-43. Review.

PMID:
15685148
14.

The varicella-zoster virus and multiple sclerosis.

Ross RT.

J Clin Epidemiol. 1998 Jul;51(7):533-5. Review.

PMID:
9674659
15.

Humoral and cellular immunity to varicella-zoster virus: an overview.

Arvin AM.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S58-60. doi: 10.1086/522123. Review. No abstract available.

PMID:
18419410
16.

Update on varicella vaccine.

Kamiya H, Ito M.

Curr Opin Pediatr. 1999 Feb;11(1):3-8. Review.

PMID:
10084076
17.

Varicella vaccination guidelines for adolescents and adults.

Ventura A.

Am Fam Physician. 1997 Mar;55(4):1220-4. Review.

PMID:
9092283
18.

Successes and remaining challenges after 10 years of varicella vaccination in the USA.

Davis MM.

Expert Rev Vaccines. 2006 Apr;5(2):295-302. Review.

PMID:
16608428
20.

[Varicella vaccination: who should be vaccinated these days?].

Hügle B, Suchowerskyj P, Schuster V.

MMW Fortschr Med. 2005 Feb 24;147(8):31-2, 34-5. Review. German.

PMID:
18441563

Supplemental Content

Support Center